title: A simulation of strategies to lower bulk tank somatic cell count below 500,000 per milliliter.
abstract: In the future, the Pasteurized Milk Ordinance may make milk quality standards more stringent by lowering the somatic cell count (SCC) limit on Grade A raw milk to 500,000/ml. Therefore, using a discrete event simulation model, we investigated the effects of the prevention of intramammary infection (as recommended by the National Mastitis Council), lactation therapy, and dry cow therapy (all seven possible combinations) on bulk tank SCC; milk, fat, and protein yields; prevalence of intramammary infection; and culling for mastitis. Untreated controls were also tested. Ten replicates of each intervention and each control were run for 2 simulated yr, including the daily sampling of 100 cows. The goal was to lower bulk tank SCC < 500,000/ml in the 2nd yr for herds that previously had stable bulk tank SCC between 500,000 and 750,000/ml. Although all strategies occasionally met this goal, on no occasion did all replicates perform without a violation in the 2nd yr of the study (median last month of violation ranged from mo 12 to 23). The combination of the prevention of intramammary infection, lactation therapy, and dry cow therapy resulted in the lowest bulk tank linear score, most replicated without a violation in the 2nd yr, fewest months with a bulk tank linear score > or = 5.3, and fewest mastitis culls. The combination of the prevention of intramammary infection and dry cow therapy also was favorably ranked (highest milk yield, fewest clinical intramammary infections during lactation, and highest percentage of uninfected cows).
authors.affiliation: Department of Animal Science, Cornell University, Ithaca, NY 14853, USA.
authors.forename: H G
authors.initials: HG
authors.lastname: Allore
authors.forename: H N
authors.initials: HN
authors.lastname: Erb
authors.forename: L W
authors.initials: LW
authors.lastname: Schruben
authors.forename: P A
authors.initials: PA
authors.lastname: Oltenacu
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002417:Cattle; D002452:Cell Count; D005260:Female; D006801:Humans; D007774:Lactation; D008055:Lipids / Q000032:analysis; D008414:Mastitis, Bovine / Q000382:microbiology / Q000517:prevention & control*; D008892:Milk / Q000737:chemistry / Q000166:cytology*; D008894:Milk Proteins / Q000032:analysis; D008954:Models, Biological; D013203:Staphylococcal Infections; D013290:Streptococcal Infections
chemical_list: D000900:Anti-Bacterial Agents; D008055:Lipids; D008894:Milk Proteins